NEW JERSEY and BOLOGNA, Italy, Oct. 14, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO; USA) and Aferetica srl (Italy), two pioneers in intensive care immunotherapy and blood purification ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion ...
WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a leader in organ transplant technologies and services, today announced the successful completion of its hundredth case using the FDA-cleared ...
DULUTH, Ga., March 24, 2026 /PRNewswire/ -- Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that Duke University Hospital became the first ...
The U.S. Food and Drug Administration today approved a device, called Xvivo Perfusion System with Steen Solution Perfusate, that can temporarily ventilate, oxygenate, and pump (perfuse) preservation ...
Nanoparticles used in drug delivery systems, bioimaging, and regenerative medicine migrate from tissues to lymphatic vessels after entering the body, so it is necessary to clarify the interaction ...
In the United States, about 30-40% of donor hearts aren't considered for transplant due to inadequate function in the donor. This leads to a drop in the number of donated hearts that are available to ...
TransMedics’ heart transport system uses warm perfusion and monitoring technologies to maintain normal function in organs retrieved from donors after brain death, with studies showing the system can ...
Wits Donald Gordon Medical Centre has introduced advanced liver perfusion technology that clinicians say could expand the ...
A clinical implementation of cell-based bone regeneration in combination with scaffold materials requires the development of efficient, controlled and reproducible seeding procedures and a tailor-made ...
Patients who received liver transplants with TransMedics' Organ Care System (OCS) liver perfusion device were less likely to experience early allograft dysfunction and ischemic biliary complications, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results